coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Hailsham PCN, Wealden · Health Inequalities Profile

    PCN U94996 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    20,930

    Registered population

    54.3% aged 18–64

    24.3%

    Aged 65+

    ICB 21.9% · England 17.9%

    3.4%

    Ethnic minority (non-White)

    1.3% Asian · England 9.6%

    17.1%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~4,953

    Core20 residents (est.)

    Resident basis; registered basis ~5,584 · see page 3

    5,925

    Hypertension register

    +3.87% in 3 yrs · England +5.60%

    372

    SMI register

    22.9% of Wealden's

    828

    COPD register

    Reviews -2.45% in 3 yrs

    Forecast to 2030

    6,792

    Hypertension patients, 2030

    +867 on today

    65.3%

    QRISK ≥20% on statins, 2030

    +2.00pp over 3 yrs

    6.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    52.5%
    Heart failure reviews trail England by 26.0 pp.

    Annual heart failure reviews fell 27.1% over 2023 to 2025 to 52.5% (England 78.5%), reaching 18.0% at Bridgeside Surgery, which may reflect recall constraints.

    49.6 pp
    Phone access varies sharply across PCN practices.

    Easy phone contact spans 49.6 pp from 22.2% at Bridgeside Surgery to 71.8% at Quintins Medical Centre (England 56.9%), which could reflect demand pressures.

    92.2%
    High BP recording alongside lagging target control.

    Recent BP recording reaches 92.2% (England 90.0%), though treatment to target fell 2.6% over 2023 to 2025 to 67.9% (England 70.3%), suggesting titration gaps.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A population with 24.3% aged 65+ and 21.5% youth may drive dual care demand

    Hailsham PCN serves 24.3% patients aged 65+ (Wealden 25.3%, NHS Sussex Integrated Care Board 21.9%, England 17.9%) and 21.5% aged 0–17 (Wealden 18.5%, NHS Sussex Integrated Care Board 17.7%, England 19.6%). Census resident ethnicity is 96.6% White (Wealden 96.0%, NHS Sussex Integrated Care Board 91.0%, England 81.1%), giving a 3.4% ethnic minority share based on Census usual residents rather than registered patients. Practice lists sum to 31,963 versus the PCN list of 20,930, creating an unresolved base discrepancy that complicates service planning.

    Age profile

    0–1721.5%
    18–6454.3%
    65+24.3%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White96.6%
    Mixed1.4%
    Asian1.3%
    Black0.4%
    Other0.3%

    Older people · falls rows are Wealden local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wealden LA)2,2462,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.4%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.3%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wealden LA)9589819552024/25
    Falls deaths, all ages, per 100,000 (Wealden LA)8.614.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile of 5.7 masks a 17.1% Core20 share spanning 19.0 pp

    Hailsham PCN has an average IMD decile of 5.7 (Wealden 7.1; NHS Sussex Integrated Care Board 6.1; England 5.5). Its 17.1% Core20 cohort exceeds Wealden (1.7%) and NHS Sussex Integrated Care Board (9.2%; England 21.0%). Practice shares span 19.0 pp: Quintins Medical Centre records 7.4% (1,037 estimated patients), Bridgeside Surgery 24.0% (1,642), and Hailsham Medical Group 26.3% (2,905). Practice estimates total 5,584, differing from the 4,953 resident decile 1+2 estimate. Deprivation is concentrated in two practices, meaning outreach and clinical capacity should focus on these lists first.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Hailsham Medical26.3% · 2,905 patients
    Bridgeside24.0% · 1,642 patients
    Quintins7.4% · 1,037 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    372

    SMI register

    1.20% recorded prevalence

    178

    Learning disability register

    0.57% recorded prevalence

    17

    Care homes, 684 beds

    In the PCN catchment

    8.8%

    Provide unpaid care

    Wealden, Census 2021

    Recorded severe mental illness prevalence is 1.2% (372 patients; England 1.0%) and learning disability is 0.6% (178 patients; England 0.6%). Catchment care homes number 17 with 684 beds. Gypsy or Irish Traveller residents comprise 0.5% (England 0.1%). In 2025, Wealden recorded 10 rough sleepers, which cannot be extrapolated to PCN level. Care home capacity and severe mental illness registers indicate specific inclusion health coordination needs.

    Severe mental illness: physical health checks

    On a 1.2% SMI register, blood pressure recording is 78.2% (England 83.4%), BMI recording is 74.4% (England 82.1%) and alcohol recording is 69.0% (England 81.8%). This pattern could reflect review constraints, testable via recall audit.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,925

    Hypertension register

    +3.87%

    Register growth, 3 yrs

    Wealden +5.15% · England +5.60%

    −2.20pp

    BP control, under 80

    ≤140/90 · −0.49pp aged 80+

    +867

    More patients by 2030

    Forecast 6,792 (20.61%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 19.1% (5,925 patients), above Wealden (17.7%), NHS Sussex ICB (16.3%) and England (15.2%). While recent blood pressure checks reached 92.2% (England 90.0%), treatment to target fell 2.6% over 2023 to 2025 to 67.9% (England +3.6%). For patients aged under 80, control is 64.6% (England 67.8%), spanning from 61.9% at Hailsham Medical Group and 64.4% at Bridgeside Surgery to 67.7% at Quintins Medical Centre. Crude prevalence does not establish unmet need, and denominators include personalised care adjustments. Trailing national control despite strong testing could reflect a post-check treatment gap, which clinical medication titration and recall audits would test.

    Lipids and statins

    Among patients with QRISK ≥ 20%, 61.1% receive lipid-lowering therapy, below England (63.6%) but above Wealden (56.8%) and NHS Sussex ICB (60.0%). Statin coverage with diabetes and cardiovascular disease is 76.7% (England 84.4%). Fewer high-risk patients receive therapy than England benchmarks, indicating a potential priority for statin initiation audits.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202649,811£2.80£2.42£1.86£139,471
    Cardiovascular (all), 202569,950£3.45£3.32£3.33£241,328

    In 2026, the PCN prescribed 49,811 lipid-regulating items at £2.80 per item (England £1.86, Wealden £2.18, NHS Sussex ICB £2.42). Across 49,811 items, this is £46,822 more than at England's unit cost. This unit-cost indicator reflects formulary or case-mix differences rather than efficiency, testable via prescribing review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +10.36%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.01%

    Asthma prevalence, PCN 3-yr % change

    Recorded COPD prevalence rose +11.1% over 2023 to 2025 to 2.7% (England 1.9%, +2.6%), but annual reviews fell 2.5% (England +2.8%) to 73.7% (England 76.4%). Asthma reviews rose +10.4% to 67.0% (England 65.7%, +4.4%) across 2,236 patients, leaving about 740 without a recorded review. Prescribing for asthma management reaches 1,711 items per 1,000 aged 5-19 (England 1,488). Diverging register growth and falling reviews may indicate review capacity constraints, testable via recall audit.

    Cancer register and children's immunisation

    Cancer prevalence is 5.3% (1,642 patients; England 3.8%). In Q1 2025/26, childhood 6-in-1 coverage at 12 months reached 100.0% (England 91.0%). Age-five MMR coverage dropped by 6.1 pp between dose 1 (96.9%) and dose 2 (90.8%), sitting 4.2 pp below the 95.0% target. This could reflect recall timing gaps, testable by checking practice reminder logs. Supplementary COVER data reflects small quarterly cohorts (65 children), representing rate differences rather than individual dropouts.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months100.0%

    England 91.0%

    6-in-1 complete primary course at 24 months94.7%

    England 92.2%

    MMR dose 1 at 24 months96.0%

    England 88.3%

    MMR dose 2 at age 590.8%

    England 82.8%

    4-in-1 pre-school booster at age 592.3%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022, 58.5% of staged cancers across NHS Sussex ICB were diagnosed at stage 1 or 2 (4,799 of 8,209 known-stage cases), 3.2 percentage points above England (55.3%) but 16.5 pp below the 75.0% national ambition by 2028. Known stage was recorded for 64.3% of 12,766 registered cancers (England 67.0%). Achieving 75.0% requires about 1,360 additional early diagnoses annually across the ICB. PCN cervical screening coverage is 71.3% (England 66.8%), though Hailsham Medical Group records 66.0%. These ICB data reflect wider system activity rather than PCN delivery. Cervical screening uptake variations may leave eligible cohorts under-screened, warranting focused recall.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), East Sussex Healthcare NHS Trust achieved 67.0% on the cancer 62-day referral to treatment standard, 18.0 pp below the 85.0% standard. Among nearest trusts, Maidstone and Tunbridge Wells NHS Trust reached 87.4% and University Hospitals Sussex NHS Foundation Trust achieved 65.2%, compared with NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). On the 28-day faster diagnosis standard, East Sussex Healthcare NHS Trust reached 84.2% (standard 75.0%; ICB 79.3%; England 79.3%). For all diagnostic tests, 5.3% waited 6+ weeks at the trust (England 23.1%).

    Pathways within standard (%)East Sussex HealthcareSussexMaidstone and Tunbridge WellsSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)84.2074.0181.7879.2979.32
    31-day treatment (96%)98.1976.7998.3590.4592.50
    62-day referral to treatment (85%)67.0465.2087.4371.5171.16
    Diagnostic waits over 6 weeks (%)East Sussex HealthcareSussexMaidstone and Tunbridge WellsEngland
    MRI6.485.620.9221.40
    CT0.488.570.519.92
    Echocardiography21.940.392.5728.48
    Colonoscopy0.7439.3519.8030.83
    Gastroscopy0.3120.0224.0329.02
    All 15 DM01 tests5.2712.956.4223.14
    Community services activityEast Sussex residentsSurrey and Sussex ICB
    Care contacts100,740309,615
    Referrals17,28566,930
    Patients with a contact25,88085,660

    Community services (residents of East Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), East Sussex recorded 105,045 community care activities and 100,740 care contacts across 25,880 patients, with adults aged 65+ accounting for 68% of contacts. Across NHS Surrey and Sussex Integrated Care Board, 316,320 care activities and 309,615 contacts were recorded. These experimental resident figures describe wider system activity, showing substantial community contact volume among older residents.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone contact spans 49.6 pp and vaccination achievement spans 50.2 pp across practices

    In 2025/26, QOF overall achievement ranged from 90.2% at Bridgeside Surgery and 90.9% at Hailsham Medical Group to 100.0% at Quintins Medical Centre (England calculated 92.5%). Vaccination and immunisation achievement spanned 50.2 pp, from 49.8% at Hailsham Medical Group and 92.4% at Bridgeside Surgery to 100.0% at Quintins Medical Centre (England calculated 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Quintins1087.471.8%82.0%76.8%
    Hailsham Medical10126.344.2%54.2%68.6%
    Bridgeside Surgery9224.022.2%63.4%61.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWealdenAssetPCNWealden
    Care homes (catchment)17 (684 beds)n/aSchools (catchment)25n/a
    Children's centres12Places of worship32161
    Libraries17Food banks (VCS)n/a1
    Homelessness support (VCS)22Day centres (VCS)n/a6
    Children and young people (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)540Primary academies58

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension titration and recall review

    On a 5,925-patient register (19.1% prevalence), treatment to target fell 2.6% over 2023 to 2025 to 67.9% (England 70.3%, +3.6%); control under 80 is 64.6% (England 67.8%), with 61.9% at Hailsham Medical Group and 64.4% at Bridgeside Surgery. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Combined SMI physical health checks

    Across 372 patients (1.2% prevalence), BP recording is 78.2% (+0.5 pp over 2023 to 2025; England 83.4%, +4.4 pp), BMI is 74.4% (England 82.1%) and alcohol recording fell 5.3 pp to 69.0% (England 81.8%, +5.4 pp). For discussion: introduce a combined check template, care-coordinator outreach, and shared partner recording pathways. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Core20 access and review alignment

    Easy phone contact spans 49.6 pp (22.2% at Bridgeside Surgery, 44.2% at Hailsham Medical Group, 71.8% at Quintins Medical Centre; England 56.9%), while heart failure reviews fell 27.1% to 52.5% across 379 patients (England 78.5%, +8.7%). Moderate effort to run.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Practice list reconciliation (p2)Aged 65+ · Aged 0-17Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension titration and recall review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Combined SMI physical health checks (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Core20 access and review alignment (p12)Core20 cohort (IMD quintile 1) · GPPS easy to contact the practice by phone · GPPS survey response rate—PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15